Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant |
| |
Authors: | Habib Tania Funk Andrew Rieck Mary Brahmandam Archana Dai Xuezhi Panigrahi Anil K Luning Prak Eline T Meyer-Bahlburg Almut Sanda Srinath Greenbaum Carla Rawlings David J Buckner Jane H |
| |
Affiliation: | Translational Research Program, Benaroya Research Institute, Seattle, WA 98101, USA. |
| |
Abstract: | The PTPN22 genetic variant 1858T, encoding Lyp620W, is associated with multiple autoimmune disorders for which the production of autoantibodies is a common feature, suggesting a loss of B cell tolerance. Lyp620W results in blunted BCR signaling in memory B cells. Because BCR signal strength is tightly coupled to central and peripheral tolerance, we examined whether Lyp620W impacts peripheral B cell homeostasis in healthy individuals heterozygous for the PTPN221858T variant. We found that these subjects display alterations in the composition of the B cell pool that include specific expansion of the transitional and anergic IgD(+)IgM(-)CD27(-) B cell subsets. The PTPN22 1858T variant was further associated with significantly diminished BCR signaling and a resistance to apoptosis in both transitional and naive B cells. Strikingly, parallel changes in both BCR signaling and composition of B cell compartment were observed in type 1 diabetic subjects, irrespective of PTPN22 genotype, revealing a novel immune phenotype and likely shared mechanisms leading to a loss of B cell tolerance. Our combined findings suggest that Lyp620W-mediated effects, due in part to the altered BCR signaling threshold, contribute to breakdown of peripheral tolerance and the entry of autoreactive B cells into the naive B cell compartment. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|